These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3414063)

  • 1. [Protective action of liposome-incorporated surface antigens of the influenza virus by different methods of immunization].
    Burkhanov SA; Mazhul' LA; Torchilin VP; Ageeva ON; Saatov TS
    Vopr Virusol; 1988; 33(2):151-3. PubMed ID: 3414063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Protective action of virosomes containing influenza virus antigens administered intranasally].
    Andzhaparidze OG; Torchilin VP; Mazhul' LA; Burkhanov SA; Ageeva ON
    Vopr Virusol; 1987; 32(1):112-4. PubMed ID: 3577103
    [No Abstract]   [Full Text] [Related]  

  • 3. [The potentials for immunization against influenza using liposome-incorporated viral surface antigens].
    Burducea O; Marcheş F; Duţu C; Grancea C; Nicolau A; Păun C
    Virologie; 1989; 40(2):97-106. PubMed ID: 2781727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The immunomodulating action of the surface antigens of the influenza A virus in experimental staphylococcal infection].
    Lavrov VF; Orlova NG; Ratgauz GL; Khodakova LP; Mazhul' LA; Kirilicheva GB; Solov'eva MS; Ageeva LA; Akatov AK
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jun; (6):53-6. PubMed ID: 1887712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T cell lysis of target cells fused with liposomes containing influenza virus haemagglutinin and neuraminidase.
    Stitz L; Huang RT; Hengartner H; Rott R; Zinkernagel RM
    J Gen Virol; 1985 Jun; 66 ( Pt 6)():1333-9. PubMed ID: 3874262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomes enhance the immunogenicity of reconstituted influenza virus A/PR/8 envelopes and the formation of protective antibody by influenza virus A/Sichuan/87 (H3N2) surface antigen.
    Gregoriadis G; Tan L; Ben-Ahmeida ET; Jennings R
    Vaccine; 1992; 10(11):747-53. PubMed ID: 1441730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
    Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
    J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice.
    Babai I; Samira S; Barenholz Y; Zakay-Rones Z; Kedar E
    Vaccine; 1999 Mar; 17(9-10):1223-38. PubMed ID: 10195636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
    Epstein SL; Misplon JA; Lawson CM; Subbarao EK; Connors M; Murphy BR
    J Immunol; 1993 Jun; 150(12):5484-93. PubMed ID: 8390536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection.
    Johansson BE; Bucher DJ; Kilbourne ED
    J Virol; 1989 Mar; 63(3):1239-46. PubMed ID: 2915381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Enhancement of the immune response to surface antigens of the influenza B virus as a result of their covalent binding with a synthetic polymer carrier].
    Petrov RV; Zhdanov VM; Kabanov VA; Khaitov RM; Norimov ASh
    Biull Eksp Biol Med; 1985 Feb; 99(2):184-6. PubMed ID: 4038611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge.
    Galarza JM; Latham T; Cupo A
    Viral Immunol; 2005; 18(1):244-51. PubMed ID: 15802970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antineuraminidase serum antibodies in natural influenza A and immunization with influenza vaccines].
    Naĭkhin AN; Tsaritsyna IM; Syrodoeva LG; Oleĭnikova EV; Gorev NE
    Vopr Virusol; 1983; (2):154-9. PubMed ID: 6868553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice.
    Ben Ahmeida ET; Gregoriadis G; Potter CW; Jennings R
    Vaccine; 1993 Oct; 11(13):1302-9. PubMed ID: 8296483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
    Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL
    J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The protective effect of hemagglutinin-specific monoclonal antibodies in experimental influenza infection].
    Nagieva FG; Krasnova NI; Nikulina VG; Andzhaparidze OG
    Vopr Virusol; 1991; 36(3):197-200. PubMed ID: 1891875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic properties and protective capacity of a cyclic peptide corresponding to site A of influenza virus haemagglutinin.
    Muller S; Plaué S; Samama JP; Valette M; Briand JP; Van Regenmortel MH
    Vaccine; 1990 Aug; 8(4):308-14. PubMed ID: 2396470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. III. Reduced generation of neuraminidase-specific helper T cells in hemagglutinin-primed mice.
    Johansson BE; Moran TM; Bona CA; Kilbourne ED
    J Immunol; 1987 Sep; 139(6):2015-9. PubMed ID: 2957444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative long-term effects in a mouse model system of influenza whole virus and purified neuraminidase vaccines followed by sequential infections.
    Johansson BE; Kilbourne ED
    J Infect Dis; 1990 Oct; 162(4):800-9. PubMed ID: 2401790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of influenza haemagglutinin and nucleoprotein as protective antigens against influenza virus infection in mice.
    Andrew ME; Coupar BE
    Scand J Immunol; 1988 Jul; 28(1):81-5. PubMed ID: 2456608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.